GlassScriptPhysician profile
David Byung Min
NPI 1205946126
$3,349.05
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,062 · 2020: $179 · 2021: $109.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,907.15 | 2019 | |
| Medtronic USA, INC. | $264.20 | 2019-2020 | |
| Nevro Corp. | $35.27 | 2020 | |
| Amgen INC. | $27.46 | 2021 | |
| Medtronic, INC. | $27.09 | 2021 | |
| Siemens Medical Solutions USA, INC. | $20.43 | 2019 | |
| Eisai INC. | $14.65 | 2021 | |
| Mdd US Operations, LLC | $14.07 | 2021 | |
| Si-Bone, INC. | $13.33 | 2020 | |
| Redhill Biopharma INC. | $12.95 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.45 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.